Immunotherapy of human cancer.
D000276:Adjuvants, Immunologic / Q000627:therapeutic use; D000951:Antigens, Neoplasm / Q000032:analysis; D000970:Antineoplastic Agents / Q000009:adverse effects; D001500:BCG Vaccine / Q000008:administration & dosage / Q000627:therapeutic use; D000939:Epitopes; D006801:Humans; D007111:Immunity, Cellular; D007165:Immunosuppression Therapy; D007167:Immunotherapy; D007978:Levamisole / Q000627:therapeutic use; D009362:Neoplasm Metastasis; D009364:Neoplasm Recurrence, Local / Q000517:prevention & control; D009369:Neoplasms / Q000188:drug therapy / Q000628:therapy*; D011379:Prognosis; D011425:Propionibacterium acnes / Q000276:immunology; D012313:RNA / Q000627:therapeutic use; D013947:Thymosin / Q000627:therapeutic use; D014165:Transfer Factor / Q000627:therapeutic use
D000276:Adjuvants, Immunologic; D000951:Antigens, Neoplasm; D000970:Antineoplastic Agents; D001500:BCG Vaccine; D000939:Epitopes; D014165:Transfer Factor; D007978:Levamisole; D013947:Thymosin; D012313:RNA